STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 116 filers reported holding STOKE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.73 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $189,667 | -34.4% | 14,039 | -34.5% | 0.02% | -33.3% |
| Q1 2024 | $289,251 | +15.3% | 21,426 | -9.2% | 0.03% | -20.6% |
| Q2 2023 | $250,783 | -16.0% | 23,592 | -34.2% | 0.03% | -15.0% |
| Q1 2023 | $298,514 | -20.1% | 35,836 | -11.4% | 0.04% | -33.3% |
| Q4 2022 | $373,464 | +86.7% | 40,462 | +159.2% | 0.06% | +100.0% |
| Q3 2022 | $200,000 | -36.1% | 15,611 | -34.0% | 0.03% | +7.1% |
| Q2 2022 | $313,000 | -63.6% | 23,670 | -7.4% | 0.03% | -50.9% |
| Q2 2021 | $860,000 | +232.0% | 25,554 | +283.9% | 0.06% | +200.0% |
| Q1 2021 | $259,000 | – | 6,657 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 10,843,681 | $146,498,130 | 99.89% |
| Lynx1 Capital Management LP | 5,185,191 | $70,051,931 | 25.27% |
| Redmile Group, LLC | 4,721,054 | $63,781,440 | 3.86% |
| Birchview Capital, LP | 210,000 | $2,837,100 | 2.63% |
| COWEN AND COMPANY, LLC | 3,365,744 | $45,471,201 | 1.25% |
| Logos Global Management LP | 1,050,000 | $14,185,500 | 1.15% |
| RTW INVESTMENTS, LP | 4,224,838 | $57,077,561 | 0.88% |
| Baker Brothers Advisors | 4,368,443 | $59,017,665 | 0.75% |
| DAFNA Capital Management LLC | 207,427 | $2,802,339 | 0.67% |
| Sio Capital Management, LLC | 175,301 | $2,368,317 | 0.64% |